QA: Moonlake Immunotherapeutics in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001821586_2023_Moonlake_Immunotherapeutics.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001821586, Moonlake Immunotherapeutics

  xvar xval
0 AssetsCurrent 76,511,332
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 49,389
3 remainder_Assets 282,580
4 LiabilitiesCurrent 7,665,446
5 LiabilitiesNoncurrent 411,157
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 23,012,463
9 ResearchAndDevelopmentExpense 42,048,954
10 remainder_Expenses 36,366
11 remainder_Revenues 0
12 remainder_NetIncome 591,732
13 remainder_ComprehensiveNetIncome 15,068,590
  yvar yval
0 Assets 76,843,301
1 Liabilities 8,076,603
2 Expenses 65,097,783
3 Revenues 0
4 StockholdersEquity 68,766,698
5 NetIncome -64,506,051
6 ComprehensiveNetIncome -56,971,756
7 BaseVar 82,839,004
8 EconomicCapitalRatiobeforeLimitedLiability 2.19
9 EconomicCapitalRatio 3.15

Edgar->Model Mapping

Feature Distribution